News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 145–180
- Matches
- 1631
- Sources here
- 23
- Companies here
- 23
Active search
1631 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Endeavour Silver (EXK) Q2 2026 Earnings Call Transcript
Endeavour Silver Corp. reported record Q1 FY2026 results, with revenue soaring 230% year-over-year to $210 million and silver equivalent production increasing by 78%, primarily due to contributions from the Kolpa and Terronera additions. The company's management is focused on further cost reductions and operational …
Independent Bank Corp. (INDB) Stock Forecasts
Argus has lowered its target price for Independent Bank Corp. (INDB) to $93.00, citing its role as a bank holding company for Rockland Trust Company. The report, dated August 12, 2026, also mentions similar target price reductions for other financial institutions. Investors can access …
Wendy's (WEN) Faces Take Private Bid As Consortium Offer Nears
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Wendy's (NasdaqGS: WEN) is reportedly the focus of an advanced take-private bid led by its largest shareholder, Trian Fund Management. Trian is said to be …
Blackstone Secured Lending Fund Revises Senior Secured Credit Agreement with Key Extensions and Adjustments
Blackstone Secured Lending Fund (NYSE:BXSL) announced a fifth amendment to its senior secured credit agreement, extending key borrowing and maturity dates while adjusting commitment amounts. The amendment prolongs the borrowing period for certain revolving commitments to August 10, 2030, and the maturity date to …
Ascendis Pharma (ASND) issues 15,060 staff warrants at $254.57 strike price
Ascendis Pharma A/S has granted 15,060 warrants to employees, with an exercise price of US $254.57 per share, matching the closing price on the grant date of August 11, 2026. These warrants vest over time, with 25% vesting after one year and the remainder …
Shoplifting survey points to financial strain as Americans struggle with costs
A new LendingTree survey reveals that 30% of American adults admit to shoplifting, an increase from 23% in 2024, with food and drinks being the most commonly stolen items. This rise is attributed to financial strain as Americans struggle with high costs, leading some …
Wendy's Shares Rise As Nelson Peltz's Trian Prepares Takeover Bid
(RTTNews) - Shares of The Wendy's Company (WEN) jumped as much as 15 percent on Wednesday after reports that Nelson Peltz's Trian Fund Management is preparing a proposal to take the struggling burger chain private. Trading in the stock was temporarily halted due to …
Wendy's Shares Jump As Nelson Peltz's Trian Prepares Takeover Bid
(RTTNews) - Shares of The Wendy's Company (WEN) jumped as much as 15 percent on Wednesday after reports that Nelson Peltz's Trian Fund Management is preparing a proposal to take the struggling burger chain private. Trading in the stock was temporarily halted due to …
Blackstone Secured Lending Fund (BXSL) extends revolver maturities, resets covenants in $2.375B facility
Blackstone Secured Lending Fund (BXSL) has amended its senior secured credit agreement, extending the maturity of most revolving commitments from August 2030 to August 2031, and the borrowing period for certain revolving commitments to August 2030. The aggregate commitments have been adjusted from $2.425 …
Wendy's stock surges on potential takeover bid: AlphaSpace breakdown
Wendy's (WEN) stock is surging on reports of a pending takeover bid to take the company private. Yahoo Finance Senior Reporter Brooke DiPalma outlines the details. Yahoo Finance's AlphaSpace is a premium investment platform that combines data, charting, news, analysis, and more to help …
Legend Biotech Shares Fall After Oppenheimer Downgrade
Legend Biotech's shares experienced a decline following an Oppenheimer downgrade from Outperform to Perform, citing potential pressures from competition and a CEO transition. Despite this, RBC maintained an Outperform rating for Legend Biotech, adjusting its price target slightly, due to positive outlooks on Carvykti …
Wendy’s Stock Soars on Report Trian Partners Prepares Bid to Take Company Private
Wendy’s tells Barron’s it would ‘thoroughly review any proposal submitted by Trian consistent with its fiduciary duties.’ Continue Reading
Nelson Peltz's Trian preparing take-private bid for Wendy's
According to a source familiar with the matter, Trian Fund Management — the firm led by Nelson Peltz — is putting together a group of investors with the goal of taking Wendy's private, Reuters reported Wednesday. Wendy's stock jumped as much as 15% on …
BXSL to MXN: Blackstone Secured Lending Fund (Dinari Tokenized Stock) Price in Mexican Peso
This article provides the current conversion rate of Blackstone Secured Lending Fund (Dinari Tokenized Stock) (BXSL) to Mexican Peso (MXN), stating that 1 BXSL is worth MX$410.86. It outlines steps on how to buy BXSL using MXN on both centralized and decentralized exchanges. The …
Legend Biotech stock downgraded at Oppenheimer (LEGN:NASDAQ)
Oppenheimer downgraded Legend Biotech (LEGN) to Perform from Outperform following the resignation of its CEO, competitive pressures, and reduced M&A prospects. The analyst cited these factors as reasons for the downgrade. Legend Biotech's shares saw a decline on Wednesday after the announcement.
Opendoor Stock Plunges 20% in a Month: Should You Buy at Low or Wait?
Opendoor Technologies Inc. (OPEN) has experienced a 20.2% stock plunge in the last month, attributed to a challenging housing market with high mortgage rates and inflationary pressures. Despite near-term profitability struggles due to its capital-intensive model, the company is pursuing acquisitions, cost reductions, and …
Sharemaestro market context Price below Trend Line 52 weeks -34.1% · Next-week setup negative 27.9%Oppenheimer downgrades Legend Biotech stock rating on M&A concerns
Oppenheimer downgraded Legend Biotech (NASDAQ:LEGN) to Perform from Outperform, lowering its price target to $40 due to diminished M&A prospects, particularly after Johnson & Johnson was removed as a potential buyer. The firm also cited concerns over the CEO's departure, financing issues, and weak …
RBC Adjusts Price Target on Legend Biotech to $58 From $59, Maintains Outperform Rating
RBC Capital Markets has adjusted its price target for Legend Biotech (LEGN) to $58, down from $59, while reiterating an Outperform rating on the stock. This revision comes amidst recent news for Legend Biotech, including a downgrade from Oppenheimer and the company reporting its …
We Think Crexendo's (NASDAQ:CXDO) Profit Is Only A Baseline For What They Can Achieve
Crexendo, Inc. (NASDAQ:CXDO) recently posted solid earnings, but the market appears to be overly pessimistic. Analysis shows that the company's statutory earnings are likely conservative due to a negative accrual ratio and the impact of unusual items. However, shareholder dilution from new share issuance …